Show simple item record

dc.contributor.authorChavassieux, P.en_US
dc.contributor.authorPortero, N.en_US
dc.contributor.authorXu, S.en_US
dc.contributor.authorEusebio, R.en_US
dc.contributor.authorDelmas, P.en_US
dc.contributor.authorZanchetta, J.en_US
dc.contributor.authorValter, I.en_US
dc.contributor.authorRecker, R.en_US
dc.date.accessioned2016-12-09T21:31:14Z
dc.date.available2016-12-09T21:31:14Z
dc.date.issued2009en_US
dc.identifier.citationChavassieux, P.; Portero, N.; Xu, S.; Eusebio, R.; Delmas, P.; Zanchetta, J.; Valter, I.; Recker, R. (2009). Comparison between 150 mg Monthly and 5 mg Daily Risedronate in Postmenopausal Osteoporosis; Effects on Bone Quality and Bone Remodelling. Bone, June 2009, 44(Supplement 2):S439. doi: http://dx.doi.org/10.1016/j.bone.2009.03.397en_US
dc.identifier.urihttp://hdl.handle.net/10504/108082
dc.titleComparison between 150 mg Monthly and 5 mg Daily Risedronate in Postmenopausal Osteoporosis; Effects on Bone Quality and Bone Remodellingen_US
dc.typeJournal Articleen_US
dc.description.volume44en_US
dc.title.workBoneen_US
dc.description.pagesS439en_US
dc.date.year2009en_US
dc.date.monthJuneen_US
dc.description.issueSupplement 2en_US
dc.program.unitSchool of Medicineen_US
dc.program.unitDepartment of Medicineen_US
dc.program.unitEndocrinologyen_US
dc.program.unitOsteoporosisen_US
dc.url.link1http://doi.org/10.1016/j.bone.2009.03.397en_US
dc.contributor.cuauthorRecker, Robert R.en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record